Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Non-metastatic Prostate Cancer × Genitourinary × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 1203 Urinary Bladder Neoplasms 381 Carcinoma, Renal Cell 329 Kidney Neoplasms 204 Neoplasms 156 Breast Neoplasms 146 Lung Neoplasms 101 Carcinoma, Transitional Cell 97 Colorectal Neoplasms 77 Testicular Neoplasms 74 Ovarian Neoplasms 62 Melanoma 60 Pancreatic Neoplasms 57 Colonic Neoplasms 50 Carcinoma, Non-Small-Cell Lung 50 Head and Neck Neoplasms 47 Stomach Neoplasms 45 Non-Muscle Invasive Bladder Neoplasms 44 Disease 43 Neoplasm Metastasis 41 Liver Neoplasms 40 Uterine Cervical Neoplasms 39 Esophageal Neoplasms 37 Prostatic Hyperplasia 36 Wilms Tumor 35 Adenocarcinoma 33 Multiple Myeloma 32 Urologic Neoplasms 30 Sarcoma 30 Recurrence 28

Interventions

enzalutamide 1 darolutamide 1 apalutamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06204302 2024-04-09

ARENA

Bayer

Non-metastatic Prostate Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡